These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18032408)

  • 21. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
    Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
    Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
    Tanaka Y; Aleksunes LM; Cui YJ; Klaassen CD
    Toxicol Sci; 2009 Apr; 108(2):247-57. PubMed ID: 19181614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
    Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
    Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effect of artemisinin extract against cholestasis induced via lithocholic acid exposure.
    Alkhedaide AQ; Ismail TA; Alotaibi SH; Nassan MA; Shehri ZSA
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30217945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy.
    Miura T; Kimura N; Yamada T; Shimizu T; Nanashima N; Yamana D; Hakamada K; Tsuchida S
    J Hepatol; 2011 Aug; 55(2):407-14. PubMed ID: 21167233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
    Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
    Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.
    Eipel C; Menschikow E; Sigal M; Kuhla A; Abshagen K; Vollmar B
    Int J Clin Exp Pathol; 2013; 6(1):80-90. PubMed ID: 23236546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.
    Donner MG; Schumacher S; Warskulat U; Heinemann J; Häussinger D
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1134-46. PubMed ID: 17916651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.
    Rippin SJ; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2001 Apr; 33(4):776-82. PubMed ID: 11283839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Function of Multidrug Resistance-associated Protein 3 in the Transport of Bile Acids under Normal Physiological and Lithocholic Acid-induced Cholestasis Conditions.
    Wang W; Zeng S; Hu M; Liu Z; Gong L
    Curr Drug Metab; 2021; 22(5):353-362. PubMed ID: 33461458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
    Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
    Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of hepatic bile acid transporters Ntcp and Bsep expression.
    Cheng X; Buckley D; Klaassen CD
    Biochem Pharmacol; 2007 Dec; 74(11):1665-76. PubMed ID: 17897632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.